Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
The Latest Guidelines: APTA Keeps You Up To Speed

Feb 22, 2021/Roundup

Evidence-based practice resources are free and easy to find at apta.org. Here are the latest additions.

The Good Stuff: Members and the Profession in the Media, June 2021

Jun 16, 2021/Roundup

Our monthly roundup of local and national reporting featuring members on a range of topics.

Confusion Assessment Method (CAM) and Family Confusion Assessment Method (FAM-CAM)

Nov 30, 2017/Test & Measure

Used for patients with suspected delirium.

Local Coverage Determinations Under Medicare

Sep 1, 2017/Column

Here's what PTs and PTAs should know about the process.

Three Ways To Stay on Top of Payment Cut, PTA Differential Advocacy

Aug 4, 2021/Roundup

With the proposed rule open for comments and legislators back home, some of our best opportunities are right now.

Study: Use of PTAs, More Therapy Intensity, Associated With Better SNF Outcomes

Jul 28, 2021/Review

An analysis of SNFs across the country echoes some themes from recent research sponsored by APTA and AOTA.

Ottawa Ankle Rules (OAR)

May 24, 2017/Test & Measure

A positive test warrants a radiograph and a negative test suggests the physical therapist can treat the patient without a radiograph.

Coronary Artery Disease (CAD)

Aug 8, 2017/Clinical Summary

PTs and PTAs are frequently involved in the care of patients at risk for, or with, coronary artery disease.

A World of Movement: The Special Olympics World Games Were Unforgettable

Jul 26, 2023/Perspective

Shortly after landing in Berlin to attend the Special Olympics World Games, or SOWG, I knew I was in for a special treat. Not even six months into my term as president of APTA Pediatrics and part of an APTA guest delegation, I had never been to an event like this and I didn't know what to expect.

Coronavirus Update: December 7

Dec 7, 2022/Roundup

APTA's message on long COVID, physical activity and vaccination effectiveness, long COVID costs, and more.